Cargando…

Effect of Doxycycline in Decreasing the Severity of Clostridioides difficile Infection in Mice

Background: Doxycycline possesses antibacterial activity against Clostridioides difficile and anti-inflammatory effects. Materials and Methods: The influence of doxycycline on the development of CDI was studied in an established animal model of CDI using C57BL/6 mice. Results: Mice intraperitoneally...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Bo-Yang, Lai, Yi-Hsin, Chiu, Chun-Wei, Hsu, Chih-Yu, Chen, Yi-Hsuan, Chen, Yueh-Lin, Tsai, Pei-Jane, Hung, Yuan-Pin, Ko, Wen-Chien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772929/ https://www.ncbi.nlm.nih.gov/pubmed/35052993 http://dx.doi.org/10.3390/antibiotics11010116

Ejemplares similares

The Role of Toll-Like Receptor-2 in Clostridioides difficile Infection: Evidence From a Mouse Model and Clinical Patients
por: Lai, Yi-Hsin, et al.
Publicado: (2021)

Corrigendum: The Role of Toll-Like Receptor-2 in Clostridioides difficile Infection: Evidence From a Mouse Model and Clinical Patients
por: Lai, Yi-Hsin, et al.
Publicado: (2021)

Peroxisome proliferator-activated receptor-γ as the gatekeeper of tight junction in Clostridioides difficile infection
por: Lai, Yi-Hsin, et al.
Publicado: (2022)

Association of Single Nucleotide Polymorphisms in Nucleotide-Binding Domain Leucine-Rich Repeat Protein 1 with Clostridioides difficile Colonization or Infection
por: Tsai, Bo-Yang, et al.
Publicado: (2023)

Impacts of Corticosteroid Therapy at Acute Stage of Hospital-Onset Clostridioides difficile Infections
por: Lee, Ching-Chi, et al.
Publicado: (2022)

Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection
por: Lee, Ching-Chi, et al.
Publicado: (2021)

Neutrophil Ratio of White Blood Cells as a Prognostic Predictor of Clostridioides difficile Infection
por: Lee, Ching-Chi, et al.
Publicado: (2022)

Application of Microbiome Management in Therapy for Clostridioides difficile Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents
por: Chiu, Chun-Wei, et al.
Publicado: (2021)

Clostridium butyricum therapy for mild-moderate Clostridioides difficile infection and the impact of diabetes mellitus
por: LEE, Jen-Chieh, et al.
Publicado: (2021)

Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection
por: Hung, Yuan-Pin, et al.
Publicado: (2015)

Risk Factors and Clinical Impact of Carbapenem-Resistant Enterobacterales Coinfections Among Hospitalized Patients with Clostridioides difficile Infection
por: Lee, Ching-Chi, et al.
Publicado: (2022)

Novel metal peroxide nanoboxes restrain Clostridioides difficile infection beyond the bactericidal and sporicidal activity
por: Yang, Li‐Xing, et al.
Publicado: (2023)

The ATP-P2X(7) Signaling Axis Is an Essential Sentinel for Intracellular Clostridium difficile Pathogen-Induced Inflammasome Activation
por: Liu, Ya-Hui, et al.
Publicado: (2018)

Corrigendum: The ATP-P2X(7) Signaling Axis Is an Essential Sentinel for Intracellular Clostridium difficile Pathogen-Induced Inflammasome Activation
por: Liu, Ya-Hui, et al.
Publicado: (2019)

Nationwide surveillance of ribotypes and antimicrobial susceptibilities of toxigenic Clostridium difficile isolates with an emphasis on reduced doxycycline and tigecycline susceptibilities among ribotype 078 lineage isolates in Taiwan
por: Hung, Yuan-Pin, et al.
Publicado: (2018)

Why Does Doxycycline Pose a Relatively Low Risk for Promotion of Clostridioides difficile Infection?
por: Xu, Dongyan, et al.
Publicado: (2022)

Vancomycin-Loaded Nanoparticles Enhance Sporicidal and Antibacterial Efficacy for Clostridium difficile Infection
por: Chen, Yi-Hsuan, et al.
Publicado: (2019)

Applications of Lactobacillus acidophilus-Fermented Mango Protected Clostridioides difficile Infection and Developed as an Innovative Probiotic Jam
por: Lee, Bao-Hong, et al.
Publicado: (2021)

Fecal microbiota transplantation and donor screening for Clostridioides difficile infection during COVID-19 pandemic
por: Chiu, Cheng-Hsun, et al.
Publicado: (2021)

Fecal microbiota transplantation for treatment of refractory or recurrent Clostridioides difficile infection in Taiwan: a cost-effectiveness analysis
por: Lan, Kai-Yen, et al.
Publicado: (2023)

Membrane Cholesterol Is Crucial for Clostridium difficile Surface Layer Protein Binding and Triggering Inflammasome Activation
por: Chen, Yu, et al.
Publicado: (2020)

Implementation of fecal microbiota transplantation in a medical center for recurrent or refractory Clostridioides difficile infection and report of preliminary outcome
por: Yeh, Yuan-Ming, et al.
Publicado: (2022)

Impact of Toxigenic Clostridium difficile Colonization and Infection among Hospitalized Adults at a District Hospital in Southern Taiwan
por: Hung, Yuan-Pin, et al.
Publicado: (2012)

Clostridium difficile Infections in Medical Intensive Care Units of a Medical Center in Southern Taiwan: Variable Seasonality and Disease Severity
por: Lee, Jen-Chieh, et al.
Publicado: (2016)

Opportunities for Nanomedicine in Clostridioides difficile Infection
por: Wang, Pei-Wen, et al.
Publicado: (2021)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Predominance of Clostridium difficile Ribotypes 017 and 078 among Toxigenic Clinical Isolates in Southern Taiwan
por: Hung, Yuan-Pin, et al.
Publicado: (2016)

Comparative genomic analysis of Clostridium difficile ribotype 027 strains including the newly sequenced strain NCKUH-21 isolated from a patient in Taiwan
por: Suzuki, Haruo, et al.
Publicado: (2017)

Survivability of Clostridioides difficile spores in fermented pork summer sausage during refrigerated storage
por: Flock, Genevieve, et al.
Publicado: (2022)

Iron Regulation in Clostridioides difficile
por: Berges, Mareike, et al.
Publicado: (2018)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

Pathogenicity and virulence of Clostridioides difficile
por: Buddle, Jessica E., et al.
Publicado: (2023)

Risk Factors of Fecal Toxigenic or Non-Toxigenic Clostridium difficile Colonization: Impact of Toll-Like Receptor Polymorphisms and Prior Antibiotic Exposure
por: Hung, Yuan-Pin, et al.
Publicado: (2013)

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection
por: Ahn, Seung Woo, et al.
Publicado: (2021)

Lauric Acid Is an Inhibitor of Clostridium difficile Growth in Vitro and Reduces Inflammation in a Mouse Infection Model
por: Yang, Hsiao-Ting, et al.
Publicado: (2018)

Doxycycline Ameliorates the Severity of Experimental Proliferative Vitreoretinopathy in Mice
por: Chen, Shun-Hua, et al.
Publicado: (2021)

Metabolism the Difficile Way: The Key to the Success of the Pathogen Clostridioides difficile
por: Neumann-Schaal, Meina, et al.
Publicado: (2019)

Clostridioides difficile therapeutics: guidelines and beyond
por: Orenstein, Robert, et al.
Publicado: (2019)

Impact of ribotype on Clostridioides difficile diagnostics
por: Rizzardi, Kristina, et al.
Publicado: (2019)

Clostridioides (Clostridium) difficile Pacemaker Infection
por: Berkefeld, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_do51mbbra7ct2vehgraia7sq2b